Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Epithelioid Hemangioendothelioma Cancer |
Description | Cravat epithelioid hemangioendothelioma research and |
Keywords | N/A |
WebSite | cravatfoundation.org |
Host IP | 15.197.142.173 |
Location | United States |
Site | Rank |
US$1,091,244
Last updated: 2023-05-14 09:32:31
cravatfoundation.org has Semrush global rank of 9,699,302. cravatfoundation.org has an estimated worth of US$ 1,091,244, based on its estimated Ads revenue. cravatfoundation.org receives approximately 125,913 unique visitors each day. Its web server is located in United States, with IP address 15.197.142.173. According to SiteAdvisor, cravatfoundation.org is safe to visit. |
Purchase/Sale Value | US$1,091,244 |
Daily Ads Revenue | US$1,008 |
Monthly Ads Revenue | US$30,220 |
Yearly Ads Revenue | US$362,629 |
Daily Unique Visitors | 8,395 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cravatfoundation.org. | A | 600 | IP: 15.197.142.173 |
cravatfoundation.org. | A | 600 | IP: 3.33.152.147 |
cravatfoundation.org. | NS | 3600 | NS Record: ns62.domaincontrol.com. |
cravatfoundation.org. | NS | 3600 | NS Record: ns61.domaincontrol.com. |
cravatfoundation.org. | MX | 3600 | MX Record: 0 cravatfoundation-org.mail.protection.outlook.com. |
cravatfoundation.org. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
cravatfoundation.org. | TXT | 3600 | TXT Record: MS=ms96967981 |
Newly Diagnosed Resources Special Topics Annual Workshop Donate Newly Diagnosed Resources Special Topics Annual Workshop Information about EHE for Patients, Their Families, and Doctors Donate Scroll EHE Epithelioid Hemangioendothelioma Cravat Foundation The Center for Research and Analysis of VAscular Tumors (CRAVAT) is an IRS approved 501(c)(3) not-for-profit organization that raises funds to increase awareness of and harness research to address rare vascular tumors. CRAVAT works with patients, clinicians and scientists to develop effective treatments for Epithelioid Hemangioendothelioma (EHE). Our Mission The central purpose of CRAVAT is to provide, on an international level, ongoing support for people with epithelioid hemangioendothelioma (EHE), and enable research that can give them better treatment for better outcomes. WE SEEK TO gather, organize, and disseminate to members of the public, including patients and physicians, scientific data about the genesis, progress and treatment |
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Thu, 23 Dec 2021 05:04:50 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS |